| Literature DB >> 22607821 |
Julie M Whitehurst1, John Schroder, Dave Leonard, Monica M Horvath, Heidi Cozart, Jeffrey Ferranti.
Abstract
BACKGROUND: Transfusion and clinical laboratory services are high-volume activities involving complicated workflows across both ambulatory and inpatient environments. As a result, there are many opportunities for safety lapses, leading to patient harm and increased costs. Organizational techniques such as voluntary safety event reporting are commonly used to identify and prioritize risk areas across care settings. Creation of functional, standardized safety data structures that facilitate effective exploratory examination is therefore essential to drive quality improvement interventions. Unfortunately, voluntarily reported adverse event data can often be unstructured or ambiguously defined.Entities:
Year: 2012 PMID: 22607821 PMCID: PMC3431246 DOI: 10.1186/2041-1480-3-4
Source DB: PubMed Journal: J Biomed Semantics
Figure 1Approach to “best-of-breed” safety classification creation. Data points of interest from multiple sources including the ICPS, MERS-TM, AHRQ Common Formats, and standards from regulatory and accrediting agencies such as the FDA, CAP, and AABB were incorporated to create comprehensive transfusion and laboratory safety classifications. Questions for each indicator utilizing internal terminology were developed, while the data points themselves were mapped to appropriate classes within the ICPS framework in the SRS database schema. For example, patient identification related data are classified under “wrong patient”, which facilitates aggregate reporting for this category.
Figure 2Blood transfusion safety reporting system reporter interface (abbreviated) post implementation of the integrated safety classification.
Transfusion report rates and time for report completion
| | | |
| Average number (± standard deviation) | 102.1 ± 14.3 | 11.5 ± 14.3 |
| | | |
| Average number (± standard deviation) | 91.6 ± 11.2 | 11.7 ± 2.5 |
| P value | 0.03* | 0.9 |
| | | |
| Median time in minutes (range) | 6.13 | 7.72 |
| (1.4-58.65) | (1.65-48.55) | |
| | | |
| Median time in minutes (range) | 7.26 | 8.81 |
| (1.72-50.17) | (2.17-32.15) | |
| P value | 0.0001†† | 0.02†† |
Pre-period: April 1, 2008–February 9, 2010; Post-period: February 10, 2010–January 31, 2011.
*Significant difference based on t-test.
†Excludes outliers ≥ 60 minutes (0.6% of reports).
††Significant difference based on Wilcoxon rank-sum test.
Laboratory report rates and time for report completion
| | | | |
| Average number (± standard deviation) | 29.1 ± 7.5 | 18.5 ± 5.8 | 0.2 ± 0.4 |
| | | | |
| Average number (± standard deviation) | 50.7 ± 9.6 | 41.5 ± 13.7 | 0.6 ± 0.6 |
| P value | <0.0001* | <0.0001* | 0.03 |
| | | | |
| Median time in minutes (range) | 9.13 | 11.15 | 19.03 |
| (1.93-52.82) | (2.67-58.98) | (8.7-30.9) | |
| | | | |
| Median time in minutes (range) | 10.27 | 11.12 | 11.9 |
| (1.87-56.73) | (2.32-56.93) | (5.37-17.63) | |
| P value | <0.0001†† | 0.9149 | 0.1655 |
Pre-period: April 1, 2008–November 9, 2009; Post-period: November 10, 2009-January 31, 2011.
*Significant difference based on t-test.
†Excludes outliers ≥60 minutes (2.3% of reports).
††Significant difference based on Wilcoxon rank-sum test.
Figure 3Clinical laboratory report numbers before and following safety classification implementation. A clear increase in the number of laboratory reports per day occurred after pathway implementation. “Pre” laboratory reports were manually classified from within the treatment and testing category for comparison to laboratory reports numbers after implementation. LCL: lower control limit; UCL: upper control limit.